drugset
drugset / Trial / NCT02191098

Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People

NCT02191098 ↗

Phase 1 Completed 10 enrolled University of Minnesota
NaSingle-groupOpen-labelTreatment

Summary

To assess the safety and tolerability of ALT-803, as well as, the potential efficacy of ALT-803 in HIV

Timeline

Start
2015-06
Primary completion
2019-09-09
Completion
2019-09-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject N-803 Protein / enzyme biologic 0.3 ug/kg —
Subject N-803 Protein / enzyme biologic 1 ug/kg —
Subject N-803 Protein / enzyme biologic 3 ug/kg —
Subject N-803 Protein / enzyme biologic 6 ug/kg —

Indications

HIV infectious disease